Business Description
Pharmadrug Inc
NAICS : 325411
SIC : 3741
ISIN : CA5134413031
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | -1.93 | |||||
Debt-to-Equity | -0.95 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -5.6 | |||||
3-Year EPS without NRI Growth Rate | 48.3 | |||||
3-Year FCF Growth Rate | 48.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.17 | |||||
9-Day RSI | 23.05 | |||||
14-Day RSI | 33.14 | |||||
6-1 Month Momentum % | -25 | |||||
12-1 Month Momentum % | -66.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.1 | |||||
Quick Ratio | 0.1 | |||||
Cash Ratio | 0.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.7 | |||||
Shareholder Yield % | -27.28 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -3252.35 | |||||
ROA % | -417.45 | |||||
ROIC % | -26.69 | |||||
ROCE % | -1644.2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.18 | |||||
EV-to-EBITDA | -0.18 | |||||
EV-to-FCF | -2.24 | |||||
Earnings Yield (Greenblatt) % | -548.14 | |||||
FCF Yield % | -97.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharmadrug Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.225 | ||
Beta | 0.23 | ||
Volatility % | 147.83 | ||
14-Day RSI | 33.14 | ||
14-Day ATR (C$) | 0.001816 | ||
20-Day SMA (C$) | 0.01325 | ||
12-1 Month Momentum % | -66.67 | ||
52-Week Range (C$) | 0.005 - 0.075 | ||
Shares Outstanding (Mil) | 107.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmadrug Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmadrug Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Pharmadrug Inc Frequently Asked Questions
What is Pharmadrug Inc(XCNQ:PHRX)'s stock price today?
When is next earnings date of Pharmadrug Inc(XCNQ:PHRX)?
Does Pharmadrug Inc(XCNQ:PHRX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |